Dr Sharon R. Lewin, incoming President of the International AIDS Society, provides an overview of the most clinically exciting papers to be presented at the upcoming conference.
Read my take on the most practice-changing clinical presentations from the recent AIDS 2022 conference in Montreal.
Read expert faculty members’ summaries of key HIV studies from AIDS 2022, including results from studies of prevention strategies, oral therapies, long-acting therapies, cure, and comorbidities.
Listen to expert insights from Chloe Orkin, MBChB, FRCP, MD, on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral and long-acting therapies, cure, and COVID-19 in people with HIV.
Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.
Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at AIDS 2022, including prevention strategies, oral therapies, long-acting therapies, cure, and COVID-19 in PWH.
Read my take on an interesting clinical presentation from the recent AIDS 2022 Conference in Montreal evaluating TDF vs TAF in HIV/HBV coinfection.
Here’s my perspective on how the DoxyPEP and ALLIANCE studies from AIDS 2022 may impact treatment of people with HIV in the Asia-Pacific region.
Conference organizers are using social media to communicate with delegates attending the meeting.
Social Media
Join the #AIDS2022 conversation
Facebook, Twitter, Instagram, LinkedIn
For more information about these resources and IAS 2022, go to www.aids2022.org.
NAM is the official provider of online scientific news reporting for the conference.
To view the coverage and to sign up for the bulletins, go to https://www.aidsmap.com/conferences/aids-2022.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.